These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

773 related articles for article (PubMed ID: 36199146)

  • 1. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
    Yan C; Niu Y; Li F; Zhao W; Ma L
    J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Prognostic Model Based on Pyroptosis-Related Genes in Pancreatic Adenocarcinoma.
    Su K; Peng Y; Yu H
    Dis Markers; 2022; 2022():9141117. PubMed ID: 35677632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma.
    Zhao S; Zhu Y; Liu H; He X; Xie J
    J Transl Med; 2023 Nov; 21(1):801. PubMed ID: 37950289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma.
    Huang Y; Gong P; Su L; Zhang M
    Sci Rep; 2023 Nov; 13(1):20870. PubMed ID: 38012210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High pyroptosis activity in pancreatic adenocarcinoma: poor prognosis and oxaliplatin resistance.
    Wang G; Chen J; Dai S; Zhang J; Gao Y; Yin L; Jiang K; Miao Y; Lu Z
    Apoptosis; 2024 Apr; 29(3-4):344-356. PubMed ID: 37848674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression profile of Gasdermin C-related genes predicts the prognosis and immunotherapy response of pancreatic adenocarcinoma.
    Xia XH; Yin WJ; Mao JF; Liu P; Qin CD; Hu JJ; Liu SY; Wang CM; Zou DH; Yang HJ; Yu Y; Huang J
    Am J Cancer Res; 2023; 13(4):1240-1258. PubMed ID: 37168356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma.
    Li S; Chen R; Luo W; Lin J; Chen Y; Wang Z; Lin W; Li B; Wang J; Yang J
    Comb Chem High Throughput Screen; 2022; 25(12):2070-2081. PubMed ID: 35048799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making.
    Zhu J; Shi Y; Lan S; Wang J; Jiang F; Tang C; Cai Y; Pan Z; Jian H; Fang H; Zhang Y; Zhong F
    Apoptosis; 2023 Jun; 28(5-6):769-782. PubMed ID: 36882663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Pyroptosis-Related Gene Signature and Effect of Silencing the
    Chen Y; Liu Y; Wang M
    Int J Gen Med; 2022; 15():3199-3213. PubMed ID: 35342302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel potential homologous repair deficiency-associated genes in pancreatic adenocarcinoma via WGCNA coexpression network analysis and machine learning.
    Liu C; Fang J; Kang W; Yang Y; Yu C; Chen H; Zhang Y; Ouyang H
    Cell Cycle; 2023 Nov; 22(21-22):2392-2408. PubMed ID: 38124367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-Metastasis-Related Genes are Potential Biomarkers for Predicting the Clinical Outcomes of Patients with Pancreatic Adenocarcinoma.
    Dong Y; Tian J; Yan B; Lv K; Li J; Fu D
    Pathol Oncol Res; 2021; 27():1609822. PubMed ID: 34290570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyroptosis regulators exert crucial functions in prognosis, progression and immune microenvironment of pancreatic adenocarcinoma: a bioinformatic and in vitro research.
    Bai Z; Xu F; Feng X; Wu Y; Lv J; Shi Y; Pei H
    Bioengineered; 2022 Jan; 13(1):1717-1735. PubMed ID: 35000541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma.
    Meng Z; Ren D; Zhang K; Zhao J; Jin X; Wu H
    Aging (Albany NY); 2020 Mar; 12(6):5048-5070. PubMed ID: 32181755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma.
    Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H
    BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pyroptosis-Related Signature Composed of GSDMC Predicts Prognosis and Contributes to Growth and Metastasis of Hepatocellular Carcinoma.
    Li M; Jiang Q; Liu X; Han L; Chen S; Xue R
    Front Biosci (Landmark Ed); 2023 Oct; 28(10):235. PubMed ID: 37919059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
    Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
    Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis.
    Li J; Lin J; Ji Y; Wang X; Fu D; Wang W; Shen B
    Cell Oncol (Dordr); 2023 Oct; 46(5):1381-1398. PubMed ID: 37138146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor mutation burden-related long non-coding RNAs is predictor for prognosis and immune response in pancreatic cancer.
    Wang C; Wang Z; Zhao Y; Jia R
    BMC Gastroenterol; 2022 Nov; 22(1):495. PubMed ID: 36451085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinoma.
    Huang Q; Peng X; Li Q; Zhu J; Xue J; Jiang H
    Front Immunol; 2023; 14():1111494. PubMed ID: 36817451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.